Vertex Pharmaceuticals Inc
NasdaqGS:VRTX
$ 315.03
+ $2.98 (0.95%)
$ 315.03
+ $2.98 (0.95%)
End-of-day quote: 03/31/2023

VRTX - Vertex Pharmaceuticals Inc Stock Prediction 2025 - 2030

20 years of reliable Vertex Pharmaceuticals Inc stock forecast. The Wall Street analysts predict Outperform for VRTX. See at a glance whether NasdaqGS:VRTX will rise in the future.

$432.60
Forecast 2023
$483.51
Forecast 2025
$632.35
Forecast 2030
Outperform
TopGraphs Quality Ranking
Forecast 2023
$432.60
Forecast 2025
$483.51
Forecast 2030
$632.35
TopGraphs Quality Ranking
Outperform

Company Info

P/E Ratio
27.8
Beta
0.48
Price-to-book Ratio
5.82
Market Cap
74.41B
TEV
61.573 B
LT Debt/Cap
0.00%
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
36.83%
Forecast 2Y
40.78%
Analyst Price Target
$323.74

Vertex Pharmaceuticals Inc Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Vertex Pharmaceuticals Inc Stock Forecast 2023

$326.00

In the last five quarters, Vertex Pharmaceuticals Inc’s Price Target has risen from $255.84 to $323.74 - a 26.54% increase. Twenty-three analysts predict that Vertex Pharmaceuticals Inc’s share price will increase in the coming year, reaching $326.00. This would represent an increase of 0.7%.

3.48%
3.48

Highest Price Target $440.00

Average Price Target $326.00

Lowest Price Target $280.00

Vertex Pharmaceuticals Inc Stock Prediction 2025

Vertex Pharmaceuticals Inc Stock Predictions for Jan 2025.

In January 2025 analysts predict a stock price of $451.38. An increase of 43.28% compared to the previous month's estimate.

Vertex Pharmaceuticals Inc Stock Predictions for Feb 2025.

In February 2025 analysts predict a stock price of $454.30. An increase of 44.21% compared to the previous month's estimate.

Vertex Pharmaceuticals Inc Stock Predictions for Mar 2025.

In March 2025 analysts predict a stock price of $457.22. An increase of 45.14% compared to the previous month's estimate.

Vertex Pharmaceuticals Inc Stock Predictions for Apr 2025.

In April 2025 analysts predict a stock price of $460.14. An increase of 46.06% compared to the previous month's estimate.

Vertex Pharmaceuticals Inc Stock Predictions for May 2025.

In May 2025 analysts predict a stock price of $463.06. An increase of 46.99% compared to the previous month's estimate.

Vertex Pharmaceuticals Inc Stock Predictions for Jun 2025.

In June 2025 analysts predict a stock price of $465.99. An increase of 47.92% compared to the previous month's estimate.

Vertex Pharmaceuticals Inc Stock Predictions for Jul 2025.

In July 2025 analysts predict a stock price of $468.91. An increase of 48.84% compared to the previous month's estimate.

Vertex Pharmaceuticals Inc Stock Predictions for Aug 2025.

In August 2025 analysts predict a stock price of $471.83. An increase of 49.77% compared to the previous month's estimate.

Vertex Pharmaceuticals Inc Stock Predictions for Sep 2025.

In September 2025 analysts predict a stock price of $474.75. An increase of 50.7% compared to the previous month's estimate.

Vertex Pharmaceuticals Inc Stock Predictions for Oct 2025.

In October 2025 analysts predict a stock price of $477.67. An increase of 51.63% compared to the previous month's estimate.

Vertex Pharmaceuticals Inc Stock Predictions for Nov 2025.

In November 2025 analysts predict a stock price of $480.59. An increase of 52.55% compared to the previous month's estimate.

Vertex Pharmaceuticals Inc Stock Predictions for Dec 2025.

In December 2025 analysts predict a stock price of $483.51. An increase of 53.48% compared to the previous month's estimate.

Vertex Pharmaceuticals Inc Stock Forecast 2030

Stock Forecast for the Price of an Vertex Pharmaceuticals Inc Share in Jan 2030.

In January 2030, analysts believe the stock price will be $600.22. An increase of 90.53% compared to the previous month's estimate.

Stock Forecast for the Price of an Vertex Pharmaceuticals Inc Share in Feb 2030.

In February 2030, analysts believe the stock price will be $603.14. An increase of 91.45% compared to the previous month's estimate.

Stock Forecast for the Price of an Vertex Pharmaceuticals Inc Share in Mar 2030.

In March 2030, analysts believe the stock price will be $606.06. An increase of 92.38% compared to the previous month's estimate.

Stock Forecast for the Price of an Vertex Pharmaceuticals Inc Share in Apr 2030.

In April 2030, analysts believe the stock price will be $608.98. An increase of 93.31% compared to the previous month's estimate.

Stock Forecast for the Price of an Vertex Pharmaceuticals Inc Share in May 2030.

In May 2030, analysts believe the stock price will be $611.90. An increase of 94.24% compared to the previous month's estimate.

Stock Forecast for the Price of an Vertex Pharmaceuticals Inc Share in Jun 2030.

In June 2030, analysts believe the stock price will be $614.82. An increase of 95.16% compared to the previous month's estimate.

Stock Forecast for the Price of an Vertex Pharmaceuticals Inc Share in Jul 2030.

In July 2030, analysts believe the stock price will be $617.74. An increase of 96.09% compared to the previous month's estimate.

Stock Forecast for the Price of an Vertex Pharmaceuticals Inc Share in Aug 2030.

In August 2030, analysts believe the stock price will be $620.66. An increase of 97.02% compared to the previous month's estimate.

Stock Forecast for the Price of an Vertex Pharmaceuticals Inc Share in Sep 2030.

In September 2030, analysts believe the stock price will be $623.59. An increase of 97.94% compared to the previous month's estimate.

Stock Forecast for the Price of an Vertex Pharmaceuticals Inc Share in Oct 2030.

In October 2030, analysts believe the stock price will be $626.51. An increase of 98.87% compared to the previous month's estimate.

Stock Forecast for the Price of an Vertex Pharmaceuticals Inc Share in Nov 2030.

In November 2030, analysts believe the stock price will be $629.43. An increase of 99.8% compared to the previous month's estimate.

Stock Forecast for the Price of an Vertex Pharmaceuticals Inc Share in Dec 2030.

In December 2030, analysts believe the stock price will be $632.35. An increase of 100.73% compared to the previous month's estimate.

P/E Ratio
27.8
Beta
0.48
Price-to-book Ratio
5.82
Market Cap
74.41B
TEV
61.573 B
LT Debt/Cap
0.00%
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
36.83%
Forecast 2Y
40.78%
Analyst Price Target
$323.74

Vertex Pharmaceuticals Inc Analyst Ratings Frequently Asked Questions

Who are the analysts watching Vertex Pharmaceuticals Inc?

The following analysts have recently covered Vertex Pharmaceuticals Inc:

Argus Research Company
Baird
Barclays
BMO Capital Markets Equity Research
BofA Global Research
CFRA Equity Research
CGS-CIMB / CIMB Research
Citigroup Inc
Cowen and Company
Daiwa Securities Co. Ltd.
Evercore ISI
Goldman Sachs
Guggenheim Securities, LLC
H.C. Wainwright & Co.
J.P. Morgan
Jefferies LLC
Marktfeld
Maxim Group
Morgan Stanley
Morningstar Inc.
Needham & Company
Oppenheimer & Co. Inc.
Piper Sandler Companies
Raymond James & Associates
RBC Capital Markets
Stifel
Truist Securities
UBS Investment Bank
Wells Fargo Securities, LLC
SVB Securities LLC
Cantor Fitzgerald & Co.
William O'Neil + Co., Incorporated
Baptista Research
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Vertex Pharmaceuticals Inc?

The following sell-side analysts have recently covered Vertex Pharmaceuticals Inc:

Hellweg, Jasper
Skorney, Brian Peter
Wang, Huidong
Seigerman, Evan David
Meacham, Geoffrey Christopher
Glickman, Stewart
Brill Bongero, Danielle Catherine
Bansal, Mohit
Nadeau, Philip M.
Nakagiri, Narumi
Bayko, Liisa Ann
Richter, Salveen Jaswal
Chattopadhyay, Debjit D.
Fein, Andrew S.
Yee, Michael Jonathan
Paraskevopoulos, Michail
Rahman, Nazibur
Harrison, Matthew Kelsey
Elfman, Rachel
Stringer, Joseph Robert
Singh, Hartaj
Kim, Guyn
Davis, Luke
Matteis, Paul Andrew
Karnauskas, Robyn Kay Shelton
Bristow, Colin Nigel
Risinger, David Reed
Brayer, Olivia Simone
Fye, Jessica Macomber
Gupta, Rajan
Majumdar, Ishan
(This information refers to the last 90 days.)

© Copyright 2022 | TopGraphs™ | All Rights Reserved

To use TopGraphs™, you must accept our Terms and Conditions and Privacy Policy